search
Back to results

Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses

Primary Purpose

Refractive Errors, Astigmatism

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
SynergEyes A2 Hybrid Contact Lens
Sponsored by
SynergEyes, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Refractive Errors focused on measuring Hybrid, contact lens, myopia, hyperopia, near sighted, astigmatism, far sighted

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Be able to understand and be willing to sign a written informed consent form
  • Age ≥18 years
  • Be willing and able to adhere to the instructions set forth in this protocol and able to keep all specific appointments
  • Have naturally occurring myopia up to -6.00 D or hyperopia up to +2.00 D (spectacle plane) with or without corneal astigmatism up to 6.00 D
  • Be in good general health, based on his/her knowledge, including normal healthy eyes
  • Possess wearable and visually functional eyeglasses
  • Have manifest refraction visual acuity equal to or better than 20/25 in each eye

Exclusion Criteria:

  • Subject requires multifocal vision correction or is wearing lenses in a monovision modality
  • Subject has lenticular astigmatism uncorrectable by normal RGP tear layer optics
  • Subject exhibits poor personal hygiene
  • Subject is currently or within 30 days prior to enrollment in this study has been an active participant in another clinical study (except SynergEyes Protocol # SI 08-05)
  • Subject is currently pregnant (to the best of the subject's knowledge), is planning a pregnancy within the next 9 months, or is lactating
  • Subject has a known sensitivity to ingredients used in contact lens care products
  • Subject has undergone refractive surgery or is currently receiving or has previously received orthokeratology treatment
  • Subject is aphakic or pseudophakic
  • Subject has ocular or systemic disease such as, but not limited to, anterior uveitis or iritis (past or present), glaucoma, Sjogren's Syndrome, lupus erythematosus, scleroderma, keratoconus, post surgical corneal irregularity or type II diabetes
  • Subject is using ocular medications for any reason or systemic medications which might interfere with contact lens wear
  • A known history of corneal hypoesthesia (reduced corneal sensitivity)
  • Slit lamp findings that would contraindicate contact lens wear, including, but not limited to:

    • Evidence of corneal ulcer, corneal infiltrates or fungal infections
    • Corneal scars within the visual axis
    • Pterygium
    • Dry eye symptoms with decrease tear levels and punctuate staining ≥ Grade 2
    • Neovascularization or ghost vessels ≥1.5mm in from the limbus
    • Seborrhoeic eczema or seborrhoeic conjunctivitis
    • History of papillary conjunctivitis that has interfered with lens wear or a current condition of Grade 2 or greater
  • Clinically significant (Grade 3 or 4) anterior segment abnormalities or any infection of the eye, lids or associated structures

Sites / Locations

  • Family Eye Care Center
  • SynergEyes, Inc.
  • Encino Optometric Center Corp.
  • Carmel Mountain Vision Care
  • VisionCare Associates, PC
  • The Koetting Associates
  • Eyesite
  • Primary Eyecare Group
  • Specialty Eyecare Group Totem Lake Vision Center
  • Snowy Range Vision Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

SynergEyes A2 Hybrid Contact Lens

Arm Description

Outcomes

Primary Outcome Measures

Confirm current SynergEyes A2 lens design by evaluating clinical performance using objective and subjective parameters

Secondary Outcome Measures

Determine the best method for fitting the SynergEyes A2 hybrid contact lens

Full Information

First Posted
January 26, 2010
Last Updated
August 24, 2010
Sponsor
SynergEyes, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01058629
Brief Title
Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses
Official Title
A 180 Day, Multicenter Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses for Daily Wear Use in the Correction of Refractive Error With or Without Astigmatism in Non-diseased Eyes
Study Type
Interventional

2. Study Status

Record Verification Date
August 2010
Overall Recruitment Status
Unknown status
Study Start Date
August 2009 (undefined)
Primary Completion Date
September 2010 (Anticipated)
Study Completion Date
September 2010 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
SynergEyes, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a multicenter study to evaluate the clinical performance of the SynergEyes A2 lens in patients with refractive errors with or without astigmatism.
Detailed Description
Hybrid contact lenses have been previously shown to be a safe and effective method to correct refractive errors with and without astigmatism. The hybrid contact lens design may provide greater visual acuity and comfort than other soft or rigid gas permeable (RGP) lenses currently available. The purpose of this study is to confirm the design of the SynergEyes A2 lens by evaluating clinical performance and, if necessary, modify certain lens parameters in order to optimize lens performance. Objective and subjective parameters will be used to evaluate the lens.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Refractive Errors, Astigmatism
Keywords
Hybrid, contact lens, myopia, hyperopia, near sighted, astigmatism, far sighted

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
125 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
SynergEyes A2 Hybrid Contact Lens
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
SynergEyes A2 Hybrid Contact Lens
Intervention Description
SynergEyes A2 is a hybrid contact lens cleared by the US Food and Drug Administration (FDA) for daily wear correction of up to +20.00 and -20.00 in eyes with astigmatism up to 6.00D and for presbyopia.
Primary Outcome Measure Information:
Title
Confirm current SynergEyes A2 lens design by evaluating clinical performance using objective and subjective parameters
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Determine the best method for fitting the SynergEyes A2 hybrid contact lens
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Be able to understand and be willing to sign a written informed consent form Age ≥18 years Be willing and able to adhere to the instructions set forth in this protocol and able to keep all specific appointments Have naturally occurring myopia up to -6.00 D or hyperopia up to +2.00 D (spectacle plane) with or without corneal astigmatism up to 6.00 D Be in good general health, based on his/her knowledge, including normal healthy eyes Possess wearable and visually functional eyeglasses Have manifest refraction visual acuity equal to or better than 20/25 in each eye Exclusion Criteria: Subject requires multifocal vision correction or is wearing lenses in a monovision modality Subject has lenticular astigmatism uncorrectable by normal RGP tear layer optics Subject exhibits poor personal hygiene Subject is currently or within 30 days prior to enrollment in this study has been an active participant in another clinical study (except SynergEyes Protocol # SI 08-05) Subject is currently pregnant (to the best of the subject's knowledge), is planning a pregnancy within the next 9 months, or is lactating Subject has a known sensitivity to ingredients used in contact lens care products Subject has undergone refractive surgery or is currently receiving or has previously received orthokeratology treatment Subject is aphakic or pseudophakic Subject has ocular or systemic disease such as, but not limited to, anterior uveitis or iritis (past or present), glaucoma, Sjogren's Syndrome, lupus erythematosus, scleroderma, keratoconus, post surgical corneal irregularity or type II diabetes Subject is using ocular medications for any reason or systemic medications which might interfere with contact lens wear A known history of corneal hypoesthesia (reduced corneal sensitivity) Slit lamp findings that would contraindicate contact lens wear, including, but not limited to: Evidence of corneal ulcer, corneal infiltrates or fungal infections Corneal scars within the visual axis Pterygium Dry eye symptoms with decrease tear levels and punctuate staining ≥ Grade 2 Neovascularization or ghost vessels ≥1.5mm in from the limbus Seborrhoeic eczema or seborrhoeic conjunctivitis History of papillary conjunctivitis that has interfered with lens wear or a current condition of Grade 2 or greater Clinically significant (Grade 3 or 4) anterior segment abnormalities or any infection of the eye, lids or associated structures
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul Kusy, OD, MS, FAAO
Organizational Affiliation
SynergEyes, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Family Eye Care Center
City
Campbell
State/Province
California
ZIP/Postal Code
95008
Country
United States
Facility Name
SynergEyes, Inc.
City
Carlsbad
State/Province
California
ZIP/Postal Code
92008
Country
United States
Facility Name
Encino Optometric Center Corp.
City
Encino
State/Province
California
ZIP/Postal Code
91436
Country
United States
Facility Name
Carmel Mountain Vision Care
City
San Diego
State/Province
California
ZIP/Postal Code
92129
Country
United States
Facility Name
VisionCare Associates, PC
City
East Lansing
State/Province
Michigan
ZIP/Postal Code
48823
Country
United States
Facility Name
The Koetting Associates
City
St. Louis
State/Province
Missouri
ZIP/Postal Code
63144
Country
United States
Facility Name
Eyesite
City
Penfield
State/Province
New York
ZIP/Postal Code
14526
Country
United States
Facility Name
Primary Eyecare Group
City
Brentwood
State/Province
Tennessee
ZIP/Postal Code
37027
Country
United States
Facility Name
Specialty Eyecare Group Totem Lake Vision Center
City
Kirkland
State/Province
Washington
ZIP/Postal Code
98034
Country
United States
Facility Name
Snowy Range Vision Center
City
Laramie
State/Province
Wyoming
ZIP/Postal Code
82070
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Study to Evaluate the Clinical Performance of SynergEyes A2 Hybrid Contact Lenses

We'll reach out to this number within 24 hrs